Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: World J Surg. 2020 Mar;44(3):876–886. doi: 10.1007/s00268-019-05121-9

Table 2.

Recurrences by location

Low-risk High-risk
Location No SYS SYS P-value No SYS SYS P-value
Intrahepatic 128 (30.0%) 260 (30.2%) 0.97 79 (50.0%) 273 (47.6%) 0.59
Pulmonary 113 (26.5%) 201 (23.3%) 0.21 56 (35.4%) 142 (24.7%) 0.007
Distant lymph nodes 28 (6.6%) 47 (5.5%) 0.42 18 (11.4%) 49 (8.5%) 0.27
Peritoneal 7 (1.6%) 18 (2.1%) 0.59 10 (6.3%) 20 (3.5%) 0.11
Local recurrence 12 (2.8%) 35 (4.1%) 0.26 5 (3.2%) 22 (3.8%) 0.69
Bone 6 (1.4%) 11 (1.3%) 0.85 4 (2.5%) 15 (2.6%) 0.95
Other 19 (4.5%) 41 (4.8%) 0.81 8 (5.1%) 34 (5.9%) 0.68